Northwestern Mutual Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.54M Sell
62,486
-623
-1% -$95.5K 0.01% 616
2025
Q4
$8.7M Sell
63,109
-1,389
-2% -$182K 0.01% 610
2025
Q3
$8.27M Sell
64,498
-2,046
-3% -$250K 0.01% 596
2025
Q2
$8.05M Sell
66,544
-53
-0.1% -$5.97K 0.01% 555
2025
Q1
$7.42M Buy
66,597
+708
+1% +$75.4K 0.01% 550
2024
Q4
$6.41M Sell
65,889
-5,053
-7% -$539K 0.01% 555
2024
Q3
$8.16M Buy
70,942
+4,062
+6% +$461K 0.01% 498
2024
Q2
$7.12M Buy
66,880
+2,689
+4% +$270K 0.01% 501
2024
Q1
$6.21M Buy
64,191
+648
+1% +$66.4K 0.01% 516
2023
Q4
$6.42M Sell
63,543
-1,745
-3% -$168K 0.01% 485
2023
Q3
$6.65M Buy
65,288
+1,777
+3% +$180K 0.01% 443
2023
Q2
$6.41M Buy
63,511
+1,021
+2% +$102K 0.01% 460
2023
Q1
$5.75M Sell
62,490
-83
-0.1% -$7.25K 0.01% 457
2022
Q4
$5.68M Sell
62,573
-2,597
-4% -$219K 0.01% 438
2022
Q3
$4.95M Sell
65,170
-3,923
-6% -$325K 0.01% 427
2022
Q2
$5.84M Buy
69,093
+9,345
+16% +$820K 0.01% 384
2022
Q1
$5.24M Buy
59,748
+28
+0% +$2.42K 0.01% 427
2021
Q4
$5.22M Sell
59,720
-6,775
-10% -$563K 0.01% 407
2021
Q3
$5.44M Buy
66,495
+757
+1% +$68.1K 0.01% 368
2021
Q2
$6M Sell
65,738
-8,525
-11% -$759K 0.01% 348
2021
Q1
$6.35M Sell
74,263
-7,717
-9% -$693K 0.01% 301
2020
Q4
$7.74M Sell
81,980
-55,708
-40% -$4.87M 0.02% 255
2020
Q3
$12M Buy
137,688
+4,701
+4% +$407K 0.03% 195
2020
Q2
$11.6M Buy
132,987
+19,088
+17% +$1.65M 0.04% 187
2020
Q1
$9.39M Buy
113,899
+18,784
+20% +$1.68M 0.04% 183
2019
Q4
$9.01M Buy
95,115
+7,265
+8% +$652K 0.03% 202
2019
Q3
$7.63M Sell
87,850
-2,911
-3% -$261K 0.03% 216
2019
Q2
$8.29M Sell
90,761
-4,547
-5% -$385K 0.03% 201
2019
Q1
$8.21M Buy
95,308
+21,036
+28% +$1.69M 0.04% 197
2018
Q4
$5.71M Buy
74,272
+9,542
+15% +$743K 0.03% 221
2018
Q3
$5M Buy
64,730
+1,644
+3% +$122K 0.03% 222
2018
Q2
$4.27M Buy
63,086
+2,842
+5% +$196K 0.02% 225
2018
Q1
$4.36M Buy
60,244
+4,461
+8% +$340K 0.03% 214
2017
Q4
$4.2M Buy
55,783
+867
+2% +$65.4K 0.03% 210
2017
Q3
$4.22M Buy
54,916
+6,228
+13% +$470K 0.03% 207
2017
Q2
$3.64M Sell
48,688
-2,259
-4% -$160K 0.03% 213
2017
Q1
$3.39M Buy
50,947
+7,410
+17% +$494K 0.03% 210
2016
Q4
$2.84M Buy
43,537
+40,610
+1,387% +$2.63M 0.03% 225
2016
Q3
$207K Sell
2,927
-37,752
-93% -$2.75M 0.01% 176
2016
Q2
$3.01M Buy
40,679
+2,705
+7% +$187K 0.04% 201
2016
Q1
$2.46M Buy
37,974
+3,246
+9% +$221K 0.04% 198
2015
Q4
$2.68M Buy
34,728
+842
+2% +$66.9K 0.05% 190
2015
Q3
$2.79M Buy
33,886
+3,782
+13% +$337K 0.07% 184
2015
Q2
$2.65M Buy
30,104
+385
+1% +$35.3K 0.07% 174
2015
Q1
$2.63M Buy
29,719
+2,510
+9% +$223K 0.07% 171
2014
Q4
$2.26M Buy
27,209
+3,516
+15% +$291K 0.07% 174
2014
Q3
$2M Buy
23,693
+2,427
+11% +$196K 0.07% 176
2014
Q2
$1.73M Buy
21,266
+69
+0.3% +$5.43K 0.07% 172
2014
Q1
$1.61M Buy
21,197
+5,184
+32% +$378K 0.07% 177
2013
Q4
$1.15M Buy
16,013
+1,713
+12% +$119K 0.05% 199
2013
Q3
$984K Buy
14,300
+1,266
+10% +$83.8K 0.05% 197
2013
Q2
$827K Buy
+13,034
New +$848K 0.05% 203

Other funds holding NVS

Northwestern Mutual Wealth Management's NVS Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Novartis (NVS) stake by 0.99% in Q1 2026, selling an estimated $95.5K and leaving 62,486 shares worth $9.54M. The position accounts for 0.01% of the portfolio, ranked #616.

Northwestern Mutual Wealth Management first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $12M in Q3 2020. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Northwestern Mutual Wealth Management held 62,486 shares of Novartis worth $9.54M as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 623 Novartis shares in Q1 2026, an estimated $95.5K.
  • Novartis made up 0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #616 holding.
  • Northwestern Mutual Wealth Management first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • Northwestern Mutual Wealth Management's Novartis position peaked at $12M in Q3 2020.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.